ProShares Ultra NASDAQ Biotechnology
0
Funds holding %
of 6,759 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
40% more capital invested
Capital invested by funds: $4.63M [Q1] → $6.5M (+$1.87M) [Q2]
14% more funds holding
Funds holding: 21 [Q1] → 24 (+3) [Q2]
2.08% more ownership
Funds ownership: 4.79% [Q1] → 6.87% (+2.08%) [Q2]
21% less call options, than puts
Call options by funds: $764K | Put options by funds: $972K
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Research analyst outlook
We haven’t received any recent analyst ratings for BIB.
Financial journalist opinion
Charts implemented using Lightweight Charts™